FDA fines 17 pharma firms over 1.5M Riyals
The Saudi Food and Drug Authority announced that 17 pharmaceutical establishments violated regulations during the months of May, June, and July 2026 for failing to comply with the systems related to the supply of pharmaceutical products and the electronic tracking system "Rased." The total fines exceeded 1.5 million Riyals. The violations included failure to report drug movements, stock shortages, and failure to provide registered products. These measures are part of the Authority's efforts to ensure the safety of pharmaceutical trading, compliance with health regulations, and the proper regulation of the industry within the Kingdom.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)